Article
Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.
Arteriosclerosis, thrombosis, and vascular biology - 1 Dec 2017
Jin Yu, Xie Yi, Ostriker Allison C, Zhang Xinbo, Liu Renjing, Lee Monica Y, Leslie Kristen L, Tang Waiho, Du Jing, Lee Seung Hee, Wang Yingdi, Sessa William C, Hwa John, Yu Jun, Martin Kathleen A
Abstract excerpt
OBJECTIVE: Drug-eluting stent delivery of mTORC1 (mechanistic target of rapamycin complex 1) inhibitors is highly effective in preventing intimal hyperplasia after coronary revascularization, but adverse effects limit their use for systemic vascular disease. Understanding the mechanism of action may lead to new treatment strategies. We have shown that rapamycin promotes vascular smooth muscle cell differentiation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
